Clinical Trials Logo

Clinical Trial Summary

Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment

Treatment Group:

Subjects treated with aBMC using the CardiAMP cell therapy system

Sham Control Group:

Subjects treated with a Sham Treatment (no introduction of the Helix transendocardial delivery catheter, no administration of aBMC)

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03455725
Study type Interventional
Source BioCardia, Inc.
Contact Peter Altman, PhD
Phone (650) 226 0135
Status Not yet recruiting
Phase Phase 3
Start date December 2018
Completion date December 2026